文献速递妇科生殖医学

早期成人型颗粒细胞瘤保留卵巢手术的生存结局

Survival outcomes of ovarian-sparing surgery for early-stage adult granulosa cell tumor.
PubMed 文献 · Am J Obstet Gynecol · 2026-10-03

这项回顾性队列研究利用美国国家癌症数据库,纳入2004至2021年诊断的18-49岁IA或IC期成人型颗粒细胞瘤患者851例,比较卵巢囊肿剔除术、单侧输卵管卵巢切除术与双侧输卵管卵巢切除术的总生存。经逆概率加权并调整治疗因素后,三种手术方式的总生存无显著差异。

要点

  • 早期成人型颗粒细胞瘤保留卵巢手术与双侧附件切除的总生存相当。
  • 囊肿剔除术对比双侧附件切除的调整HR为0.72(95%CI 0.23-2.28)。
  • 单侧附件切除对比双侧附件切除的调整HR为1.06(95%CI 0.53-2.15)。

核心结论

  • 在18-49岁早期成人型颗粒细胞瘤患者中,保留卵巢手术(囊肿剔除或单侧输卵管卵巢切除)的总生存与双侧输卵管卵巢切除相当。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库,纳入2004-2021年组织学确诊的18-49岁IA或IC期成人型颗粒细胞瘤女性患者。
  • 共851例患者,按手术方式分为囊肿剔除术76例(8.9%)、单侧输卵管卵巢切除术445例(52.3%)和双侧输卵管卵巢切除术330例(38.8%)。
  • 采用倾向评分逆概率加权,Kaplan-Meier法估计2年和5年总生存,Cox比例风险回归估计手术方式与生存的关联并调整治疗因素。

主要发现

  • 双侧输卵管卵巢切除组中82.7%同时行子宫切除,单侧输卵管卵巢切除组为22.9%。
  • 年轻患者(18-39岁)更常接受保留卵巢手术,40-49岁患者更常接受双侧输卵管卵巢切除(P<.001)。
  • 中位随访77.5个月(四分位距39.2-135.8)。
  • 逆概率加权并调整治疗因素后,各手术组总生存无显著差异:囊肿剔除vs双侧切除调整HR 0.72(95%CI 0.23-2.28),单侧切除vs双侧切除调整HR 1.06(95%CI 0.53-2.15)。
  • 按年龄(18-39岁和40-49岁)及分期(IA和IC)分层分析结果一致。

临床怎么用

  • 对年轻早期成人型颗粒细胞瘤患者,可考虑保留卵巢手术以保留生育和内分泌功能。
  • 决策时需结合年龄、分期及是否需子宫切除等治疗因素综合评估。

局限性

  • 原文指出需进一步研究比较各手术组的复发和無病生存,以辅助临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence regarding the oncologic safety of ovarian-preserving surgery for the management of early-stage adult granulosa cell tumors remains limited and inconsistent. OBJECTIVE: To examine overall survival among premenopausal patients with early-stage adult granulosa cell tumors undergoing ovarian-sparing surgery (cystectomy or unilateral salpingo-oophorectomy), in comparison to bilateral salpingo-oophorectomy. STUDY DESIGN: This retrospective cohort study used the National Cancer Database to identify female patients aged 18 to 49 years with histologically confirmed stage IA or IC adult granulosa cell tumors diagnosed between 2004 and 2021. Patients were categorized by surgical approach: ovarian cystectomy, unilateral salpingo-oophorectomy, or bilateral salpingo-oophorectomy. Propensity score‑based inverse probability of treatment weighting was used to account for differences in baseline patient characteristics across the surgical groups. Two-year and 5-year overall survival was estimated based on Kaplan-Meier methods after applying inverse probability of treatment weighting. The association between surgical group and survival was estimated using Cox proportional hazards regression with inverse probability of treatment weighting and adjustment for treatment factors (hysterectomy, lymphadenectomy, and chemotherapy). RESULTS: Of 851 patients identified, 76 (8.9%) underwent cystectomy, 445 (52.3%) underwent unilateral salpingo-oophorectomy, and 330 (38.8%) underwent bilateral salpingo-oophorectomy. Concurrent hysterectomy was performed in 82.7% of the bilateral salpingo-oophorectomy group, compared with 22.9% of the unilateral salpingo-oophorectomy group. Younger patients (aged 18-39 years) more frequently underwent ovarian-sparing procedures, whereas those aged 40 to 49 years more frequently underwent bilateral salpingo-oophorectomy (P<.001). Median follow-up was 77.5 months (interquartile range, 39.2-135.8). After inverse probability of treatment weighting and adjustment for treatment factors, there was no significant difference in overall survival across the surgical groups (adjusted hazard ratio [95% confidence interval], 0.72 [0.23-2.28] for cystectomy vs bilateral salpingo-oophorectomy and 1.06 [0.53-2.15] for unilateral salpingo-oophorectomy vs bilateral salpingo-oophorectomy). Findings remained consistent when the analysis was stratified by age (18-39 and 40-49 years) and stage (IA and IC). CONCLUSION: Among patients aged 18 to 49 years with early-stage adult granulosa cell tumors, ovarian-preserving surgery (cystectomy or unilateral salpingo-oophorectomy) was associated with overall survival comparable to bilateral salpingo-oophorectomy. Further research comparing recurrence and disease-free survival across these surgical groups is needed to facilitate clinical decision-making.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Van Biema FL, Huang Y, Ludmir D, et al. Survival outcomes of ovarian-sparing surgery for early-stage adult granulosa cell tumor. Am J Obstet Gynecol. 2026. PMID: 42826858. doi:10.1016/j.ajog.2026.09.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。